Vanguard Group’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,976,720
| Closed | -$166M | – | 4562 |
|
|
2023
Q3 | $166M | Buy |
6,976,720
+773,465
| +12% | +$14.6M | ﹤0.01% | 1532 |
|
|
2023
Q2 | $101M | Sell |
6,203,255
-70,258
| -1% | -$1.16M | ﹤0.01% | 1846 |
|
|
2023
Q1 | $109M | Sell |
6,273,513
-116,356
| -2% | -$2.09M | ﹤0.01% | 1791 |
|
|
2022
Q4 | $120M | Sell |
6,389,869
-114,964
| -2% | -$2.22M | ﹤0.01% | 1706 |
|
|
2022
Q3 | $115M | Sell |
6,504,833
-48,006
| -0.7% | -$833K | ﹤0.01% | 1701 |
|
|
2022
Q2 | $114M | Buy |
6,552,839
+62,500
| +1% | +$1.19M | ﹤0.01% | 1740 |
|
|
2022
Q1 | $136M | Sell |
6,490,339
-5,361
| -0.1% | -$103K | ﹤0.01% | 1767 |
|
|
2021
Q4 | $116M | Buy |
6,495,700
+331,924
| +5% | +$5.33M | ﹤0.01% | 1913 |
|
|
2021
Q3 | $86.9M | Buy |
6,163,776
+183,958
| +3% | +$2.86M | ﹤0.01% | 2059 |
|
|
2021
Q2 | $99.2M | Buy |
5,979,818
+82,629
| +1% | +$1.48M | ﹤0.01% | 2006 |
|
|
2021
Q1 | $107M | Buy |
5,897,189
+343,632
| +6% | +$6.78M | ﹤0.01% | 1912 |
|
|
2020
Q4 | $101M | Buy |
5,553,557
+152,143
| +3% | +$2.41M | ﹤0.01% | 1823 |
|
|
2020
Q3 | $68.8M | Sell |
5,401,414
-144,651
| -3% | -$1.85M | ﹤0.01% | 1856 |
|
|
2020
Q2 | $60.9M | Buy |
5,546,065
+135,946
| +3% | +$1.41M | ﹤0.01% | 1909 |
|
|
2020
Q1 | $56.5M | Buy |
5,410,119
+191,892
| +4% | +$2.47M | ﹤0.01% | 1812 |
|
|
2019
Q4 | $83.9M | Sell |
5,218,227
-405,351
| -7% | -$6.7M | ﹤0.01% | 1867 |
|
|
2019
Q3 | $88.1M | Buy |
5,623,578
+58,842
| +1% | +$979K | ﹤0.01% | 1799 |
|
|
2019
Q2 | $111M | Buy |
5,564,736
+104,036
| +2% | +$1.94M | ﹤0.01% | 1695 |
|
|
2019
Q1 | $91.9M | Buy |
5,460,700
+146,955
| +3% | +$2.55M | ﹤0.01% | 1792 |
|
|
2018
Q4 | $80.5M | Sell |
5,313,745
-3,488
| -0.1% | -$59.8K | ﹤0.01% | 1799 |
|
|
2018
Q3 | $107M | Buy |
5,317,233
+121,075
| +2% | +$2.57M | ﹤0.01% | 1770 |
|
|
2018
Q2 | $101M | Buy |
5,196,158
+119,526
| +2% | +$1.89M | ﹤0.01% | 1773 |
|
|
2018
Q1 | $69.3M | Buy |
5,076,632
+52,824
| +1% | +$696K | ﹤0.01% | 1908 |
|
|
2017
Q4 | $68.2M | Buy |
5,023,808
+134,328
| +3% | +$1.93M | ﹤0.01% | 1912 |
|
|
2017
Q3 | $76.9M | Buy |
4,889,480
+198,114
| +4% | +$3.2M | ﹤0.01% | 1843 |
|
|
2017
Q2 | $80.7M | Buy |
4,691,366
+170,698
| +4% | +$2.59M | ﹤0.01% | 1783 |
|
|
2017
Q1 | $68.9M | Buy |
4,520,668
+113,042
| +3% | +$1.66M | ﹤0.01% | 1846 |
|
|
2016
Q4 | $58M | Buy |
4,407,626
+213,059
| +5% | +$2.73M | ﹤0.01% | 1894 |
|
|
2016
Q3 | $47.5M | Buy |
4,194,567
+176,429
| +4% | +$2.12M | ﹤0.01% | 1952 |
|
|
2016
Q2 | $47.9M | Sell |
4,018,138
-850,765
| -17% | -$11.4M | ﹤0.01% | 1925 |
|
|
2016
Q1 | $74.2M | Buy |
4,868,903
+87,495
| +2% | +$1.33M | ﹤0.01% | 1669 |
|
|
2015
Q4 | $77.1M | Buy |
4,781,408
+113,699
| +2% | +$1.66M | 0.01% | 1645 |
|
|
2015
Q3 | $58.3M | Buy |
4,667,709
+85,172
| +2% | +$1.17M | ﹤0.01% | 1784 |
|
|
2015
Q2 | $75.9M | Buy |
4,582,537
+1,056,108
| +30% | +$17M | 0.01% | 1715 |
|
|
2015
Q1 | $56.4M | Buy |
3,526,429
+540,884
| +18% | +$8.95M | ﹤0.01% | 1846 |
|
|
2014
Q4 | $46.5M | Buy |
2,985,545
+210,331
| +8% | +$3.07M | ﹤0.01% | 1873 |
|
|
2014
Q3 | $38.2M | Sell |
2,775,214
-220,037
| -7% | -$3.34M | ﹤0.01% | 1937 |
|
|
2014
Q2 | $48.1M | Sell |
2,995,251
-51,301
| -2% | -$811K | ﹤0.01% | 1852 |
|
|
2014
Q1 | $51.4M | Buy |
3,046,552
+104,365
| +4% | +$1.89M | ﹤0.01% | 1790 |
|
|
2013
Q4 | $62M | Buy |
2,942,187
+165,945
| +6% | +$3.74M | 0.01% | 1648 |
|
|
2013
Q3 | $60.3M | Buy |
2,776,242
+104,901
| +4% | +$2.24M | 0.01% | 1589 |
|
|
2013
Q2 | $50M | Buy |
+2,671,341
| New | +$48.7M | 0.01% | 1638 |
|
Other funds holding NXGN
Vanguard Group's NXGN Position: Q4 2023 in Review
Vanguard Group sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 6,976,720 shares — an estimated $166M sold.
Vanguard Group first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $166M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Vanguard Group reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Vanguard Group sold 6,976,720 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $166M.
- Vanguard Group first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
- Vanguard Group's NextGen Healthcare, Inc. Common Stock position peaked at $166M in Q3 2023.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.